COMPOSITIONS AND METHODS RELATED TO MIR-184 MODULATION OF NEOVASCULARIZATION OR ANGIOGENESIS

摘要

The present invention provides a method of identifying or classifying a patient as having a condition characterized by aberrant neovascularization and suitable for treatment with a synthetic miR-184 molecule. The method includes the step of determining the expression level of miR-184 (SEQ. ID. NO:2) in a biological sample obtained from a tissue characterized by aberrant neovascularization.